Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZG9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,481
Award facts
- Contract value 100% obligated
- $7,481.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/mL. The delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, carries no set-aside designation, indicating the awardee competed successfully in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations.
DMS Pharmaceutical Group has held its PPV-G GEN V prime vendor contract since November 13, 2025, with a ceiling value of $499,999,999 and performance extending through December 31, 2036. As a critical supplier within the federal pharmaceutical supply chain, the company distributes a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The company's demonstrated performance across numerous prior delivery orders and its established position as a regional prime vendor contractor underscore its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense medical system.
Quick answers
Who was awarded contract SPE2DR26FCZG9?
SPE2DR26FCZG9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FCZG9 worth?
The government has obligated $7,481 on SPE2DR26FCZG9.
Is contract SPE2DR26FCZG9 an order under another contract?
Yes. SPE2DR26FCZG9 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZG9 competed?
The extent of competition for SPE2DR26FCZG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award